Unexpected peaks in tandem mass spectra due to reaction of product ions with residual water in mass spectrometer collision cells


Mahnaz Farahani, Pedatsur Neta, Yamil Simón-Manso, Yuxue Liang, Xiaoyu Yang and Stephen E Stein

National Institute of Standards and Technology, USA

: J Diagnos Tech Biomed Anal

Abstract


Rationale: Certain product ions in electrospray ionization tandem mass spectrometry are found to react with residual water in the collision cell. This reaction often leads to the formation of ions that cannot be formed directly from the precursor ions, and this complicates the mass spectra and may distort MRM (multiple reaction monitoring) results. Methods: Various drugs, pesticides, metabolites, and other compounds were dissolved in acetonitrile/water/formic acid and studied by electrospray ionization mass spectrometry to record their MS2 and MSn spectra in several mass spectrometers (QqQ, QTOF, IT, and Orbitrap HCD). Certain product ions were found to react with residual water in collision cells. The reaction was confirmed by MSn studies and the rate of reaction was determined in the IT instrument using zero collision energy and variable activation times. Results: Examples of product ions reacting with water include phenyl and certain substituted phenyl cations, benzoyl-type cations formed from protonated folic acid and similar compounds by loss of the glutamate moiety, product ions formed from protonated cyclic siloxanes by loss of methane, product ions formed from organic phosphates, and certain negative ions. The reactions of product ions with residual water varied greatly in their rate constant and in the extent of reaction (due to isomerization). Conclusions: Various types of product ions react with residual water in mass spectrometer collision cells. As a result, tandem mass spectra may contain unexplained peaks and MRM results may be distorted by the occurrence of such reactions. These often unavoidable reactions must be taken into account when annotating peaks in tandem mass spectra and when interpreting MRM results.

Biography


Mahnaz.Farahani@fda.hhs.gov

Track Your Manuscript

Awards Nomination

GET THE APP